Abzyme Therapeutics LLC
Abzyme Therapeutics LLC is a small business in Pottstown, PA registered on SAM.gov to bid on federal contracts. It has won 14 small business R&D awards worth $6.7 million through the SBIR and STTR programs since 2016, according to SBIR.gov.
- UEI
- H2MLEFWV36N6
- CAGE code
- 62ES6
- SAM.gov registration
- Active
Registration details
| Legal business name | Abzyme Therapeutics LLC |
|---|---|
| Unique Entity ID (UEI) | H2MLEFWV36N6 |
| CAGE code | 62ES6 |
| Location | Pottstown, PA |
| SAM.gov registration | Active through Jan 2, 2027 |
| Business started | 2010 |
| Primary NAICS code | 541714: Research and Development in Biotechnology (except Nanobiotechnology) |
| Website | www.abzymetx.com |
Certifications and business types
- Minority-owned (self-reported in SAM.gov)
SBA certifications let a business compete for set-aside contracts. See set-aside contracts explained.
SBIR and STTR awards
Abzyme Therapeutics LLC has won 14 small business R&D awards worth $6.7 million through the SBIR and STTR programs since 2016, 3 of them Phase II. Funded by NIH and CBD.
| Awarded | Agency | Project | Amount |
|---|---|---|---|
| Mar 1, 2024 | NIH | SBIR Phase II Multi-specific long-acting antibodies for the treatment of retinal neovascular diseases | $1.7 million |
| May 22, 2023 | NIH | SBIR Phase I Novel immune-escape uricase for treatment of hyperuricemia | $299,999 |
| Sep 15, 2021 | NIH | SBIR Phase I Brain-cell penetrating antibodies for treatment of progressive multiple sclerosis | $399,107 |
| Sep 1, 2019 | NIH | SBIR Phase I Multi-specific long-acting antibodies for the treatment of retinal neovascular diseases | $299,989 |
| Aug 14, 2019 | NIH | SBIR Phase I Pemphigus-specific T cell engagers for pemphigus targeted immunotherapy | $280,352 |
| Nov 15, 2017 | CBD | SBIR Phase II Medical Countermeasure Development for Viral Induced Encephalitis Using Single DomainAntibodies | $499,999 |
| Sep 25, 2017 | NIH | SBIR Phase I Modular antibody engineering to overcome the blood brain barrier | $236,646 |
| Sep 15, 2017 | NIH | SBIR Phase I Development Of Arginine Linkage Specific Antibodies | $224,926 |
Showing the newest 8. Award data from SBIR.gov. SBIR and STTR awards are grants or contracts for R&D, so some don't appear in its federal contract history.
Federal contract history
USAspending.gov shows no federal prime contracts for this UEI in the last five years. Its SBIR and STTR awards are listed above.
NAICS codes Abzyme Therapeutics LLC is small under
On its SAM.gov registration, Abzyme Therapeutics LLC meets the SBA size standard for these industries, so it can bid on small business set-asides that use them.
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
Open contracts in Abzyme Therapeutics LLC's NAICS codes
36 open federal opportunities on SAM.gov use a NAICS code Abzyme Therapeutics LLC is small under. These are due soonest.
- SURPASS Webinar and Proposers' Day Information
Due in 2 daysOct 12, 2026
- Simulation-augmented, Real-time Platform Adaptive Seamless Trials (SURPASS)
Due in 2 daysOct 12, 2026
- UNifying Imaging with QUantum Entanglement (UNIQUE) Proposers' Day
Due in 3 daysOct 14, 2026
- Request for Information (RFI) on Identifying Basic Research Challenges to Accelerate United States Biotechnology Leadership
Due in 4 daysOct 15, 2026
- Protein ENGineering (PENG)
✦ DARPA's Defense Sciences Office wants teams to build a platform that can edit existing (endogenous) proteins inside living cells, without permanently changing DNA. It is a…
Due in 8 daysOct 19, 2026
Similar small businesses
Other small businesses with the same primary NAICS code (541714) that have won federal contracts, starting with Pennsylvania:
- Integral Molecular Inc, Philadelphia, PA
- XCMR Inc, Penn Valley, PA
- Tela Bio, Inc., Malvern, PA
- Aptagen LLC, Jacobus, PA
- Cherokee Nation Strategic Programs, L.L.C., Tulsa, OK
- Axle Informatics, LLC, North Bethesda, MD
Frequently asked questions
What is Abzyme Therapeutics LLC's CAGE code?
Abzyme Therapeutics LLC's CAGE code is 62ES6. The Defense Logistics Agency assigns CAGE codes when a business registers on SAM.gov.
What is Abzyme Therapeutics LLC's UEI?
Abzyme Therapeutics LLC's Unique Entity ID (UEI) is H2MLEFWV36N6. SAM.gov assigns the UEI, and it identifies the business across the federal government.
Is Abzyme Therapeutics LLC's SAM.gov registration active?
Yes, as of the latest SAM.gov public data, Abzyme Therapeutics LLC's registration is active through Jan 2, 2027. Registrations are renewed every year.
Is Abzyme Therapeutics LLC a small business?
Abzyme Therapeutics LLC is registered on SAM.gov as small under 1 NAICS code, including its primary code, 541714. Size is set per NAICS code, so a business can be small for some contracts and not others.
Keep going
- Look up another business's CAGE code or UEI
- Check a SAM.gov registration's status
- How to become a government subcontractor
Registration details come from SAM.gov's public entity extract and contract figures from USAspending.gov. Contact names and street addresses are left out. To change these details, update the registration on SAM.gov. To ask us to remove this page, email hello@fedready.us.